Akademik Veri Yönetim Sistemi
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, cilt.35, sa.6, ss.307-315, 2024 (SCI-Expanded)
Thrombotic thrombocytopenic purpura (TTP) is one of the rare group disorders classified as thrombotic microangiopathies (TMAs). Approximately 90% of TTP developed immune-mediation by the formation of antibodies against the enzyme ADAMTS-13. The exact cause is unknown. To establish an association between human leukocyte antigen (HLA) and autoimmune basis, as susceptibility or protection against the disease, we contributed a study aiming to evaluate the role of HLA in immune-mediated TTP (iTTP). Considering epidemiological factors such as age, sex, ethnicity, and geographical origins, we contributed the study in our country, Turkey, which consist of a very heterogeneous population. Patients' data collection was retrospectively from electronic database on two University hospitals having big therapeutic apheresis service. Control arm was healthy people registered as stem cell donors matched in terms of age and sex. The frequency of HLA-DRB1 and HLA-DQB1 alleles between acquired TTP and the control group was compared using the chi-square method. Yates correction and logistic regression were performed on these results. A total of 75 iTTP patients and 150 healthy individuals enrolled to the study. HLA-DRB1 & lowast;11, HLA-DQB1 & lowast;03, HLA-DRB1 & lowast;11:01, HLA-DRB1 & lowast;14:01, HLA-DRB1 & lowast;13:05, HLA-DRB1 & lowast;11 + HLA-DQB1 & lowast;03 allele pair and HLA-DRB1 & lowast;15 + HLA- DQB1 & lowast;06 were proved to be susceptibility allele pairs for iTTP. HLA-DRB1 & lowast;15, HLA-DRB1 & lowast;01:01, HLA-DRB1 & lowast;07:01, HLA-DRB1 & lowast;13:01, HLA-DRB1 & lowast;14:54, HLA-DQB1 & lowast;05:01, HLA-DQB1 & lowast;02:02 and HLA-DRB1 & lowast;07 + HLA-DQB1 & lowast;02 allele pair were found to be protective against iTTP. Our findings support an association with iTTP across very heterogenous populations in Turkey.